Corrigendum to “Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings” [Obes. Pillars, Volume 11, September 2024, 100112]

• Khushboo Gala,
• Wissam Ghusn,
• Vitor Brunaldi,
• Christopher McGowan,
• Reem Z. Sharaiha,
• Daniel Maselli,
• Brandon Vanderwel,
• Prashant Kedia,
• Michael Ujiki,
• Eric Wilson,
• Eric J. Vargas,
• Andrew C. Storm,
• Barham K. Abu Dayyeh

Affiliations

Khushboo Gala

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Wissam Ghusn

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Vitor Brunaldi

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Christopher McGowan

True You Weight Loss, Cary, NC, USA

Reem Z. Sharaiha

Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, USA

Daniel Maselli

True You Weight Loss, Cary, NC, USA

Brandon Vanderwel

Eviva, Shoreline, WA, USA

Prashant Kedia

Methodist Dallas Medical Center, Dallas, TX, USA

Michael Ujiki

NorthShore University Health System, Evanston, IL, USA

Eric Wilson

University of Texas Health Science Center – Houston, Houston, TX, USA

Eric J. Vargas

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Andrew C. Storm

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Barham K. Abu Dayyeh

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; Corresponding author.